» Authors » Angelika B Reske-Kunz

Angelika B Reske-Kunz

Explore the profile of Angelika B Reske-Kunz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 344
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Sudowe S, Hohn Y, Renzing A, Maxeiner J, Montermann E, Habermeier A, et al.
Amino Acids . 2020 Feb; 52(3):411-424. PMID: 32008091
We have previously shown that particle-mediated epidermal delivery (PMED) of plasmids encoding β-galactosidase (βGal) under control of the fascin-1 promoter (pFascin-βGal) yielded selective production of the protein in skin dendritic...
2.
Bros M, Youns M, Kollek V, Buchmuller D, Bollmann F, Seo E, et al.
Front Pharmacol . 2018 Sep; 9:915. PMID: 30174602
Dendritic cells (DCs) are pivotal for the induction and maintenance of antigen-specific tolerance and immunity. miRNAs mediate post-transcriptional gene regulation and control in part the differentiation and stimulation-induced immunogenic function...
3.
Castor T, Yogev N, Blank T, Barwig C, Prinz M, Waisman A, et al.
PLoS One . 2018 Feb; 13(2):e0191927. PMID: 29408931
In this study we analysed the effects of prophylactic biolistic DNA vaccination with plasmids encoding the encephalitogenic protein myelin oligodendrocyte glycoprotein (MOG) on the severity of a subsequently MOGp35-55-induced EAE...
4.
Trojandt S, Bellinghausen I, Reske-Kunz A, Bros M
Hum Immunol . 2016 Sep; 77(12):1223-1231. PMID: 27593566
Immature dendritic cells (iDCs) and tolerogenic DCs are essential for the induction and maintenance of peripheral tolerance. Tumors produce immuno-modulatory factors which imprint a pro-tolerogenic, maturation-resistant state in DCs. Here...
5.
Bros M, Montermann E, Cholaszczynska A, Reske-Kunz A
Int Immunopharmacol . 2016 Apr; 35:174-184. PMID: 27070502
Phosphodiesterase 4 (PDE4) inhibitors serve to prevent degradation of the intracellular second messenger cAMP, resulting in broad anti-inflammatory effects on different cell types including immune cells. Agents that elevate cAMP...
6.
Kafer R, Usanova S, Montermann E, Loquai C, Reske-Kunz A, Bros M
Int Immunopharmacol . 2016 Jan; 32:118-124. PMID: 26824774
Many tumors are characterized by mutation-induced constitutive activation of β-catenin which promotes tumor growth and survival. Consequently, the development of specific β-catenin inhibitors for tumor therapy has come into the...
7.
Mohr C, Gross C, Bros M, Reske-Kunz A, Biesinger B, Thoma-Kress A
Virology . 2015 Sep; 485:481-91. PMID: 26363219
Adult T-cell leukemia/lymphoma is a highly infiltrative neoplasia of CD4(+) T-lymphocytes that occurs in about 5% of carriers infected with the deltaretrovirus human T-cell leukemia virus type 1 (HTLV-1). The...
8.
Raker V, Stein J, Montermann E, Maxeiner J, Taube C, Reske-Kunz A, et al.
Immunobiology . 2014 Dec; 220(4):490-9. PMID: 25468560
The mechanisms of tolerance induction occurring in the course of allergen-specific immunotherapy have not been elucidated in full detail. Our study aimed to characterize high zone tolerance in mouse models...
9.
Trojandt S, Reske-Kunz A, Bros M
J Exp Clin Cancer Res . 2014 Feb; 33:16. PMID: 24524692
Background: The chaperon heat shock protein 90 (HSP90) constitutes an important target for anti-tumor therapy due to its essential role in the stabilization of oncogenes. However, HSP90 is ubiquitously active...
10.
Hausding M, Jurk K, Daub S, Kroller-Schon S, Stein J, Schwenk M, et al.
Basic Res Cardiol . 2013 Sep; 108(6):386. PMID: 24061433
CD40 ligand (CD40L) is involved in the vascular infiltration of immune cells and pathogenesis of atherosclerosis. Additionally, T cell CD40L release causes platelet, dendritic cell and monocyte activation in thrombosis....